ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR
Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
One Nucleus is a dynamic not-for-profit Life Sciences and Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector. This support helps them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D has always been impactful in driving social and economic progress.
The April edition of our People Pathways newsletter is available to read here!
Featuring:
✅ One Nucleus upcoming courses
✅ Blog including key takeaways from the 31 March skills roundtable
✅ Cyber awareness survey
✅ UCL Summer Courses
RESI Boston June 2025, will take place on June 16 at the Westin Copley Place during the Convention Week, followed by three (3) days of virtual partnering on June 17-18, 23. Virtual partnering on the June 23 gives you a chance to extend your Convention-week partnering! This hybrid format combines the benefits of in-person networking with the flexibility of online interactions.
Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development
Amsbio has launched a new range of Deubiquitinating (DUB) enzyme assay kits supplied in a convenient and easy-to-use 96-well assay format. With minimal setup required and no need for substrate preparation, these ready-to-use kits accelerate routine DUB activity assays without compromising data quality.
The Milner Therapeutics Symposium takes place annually in Cambridge, UK, hosting ~500 delegates in person and >250 online. The Symposium is an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma and biotech towards new treatments. It is our key networking event to foster collaborations within the Milner Therapeutics Institute partner organisations.
by Monalisa Breazu, Learning & Development Administrator, One Nucleus
At a recent One Nucleus roundtable, a diverse group of professionals came together to talk candidly about this exact issue. From HR and hiring leads to scientists, educators, and entrepreneurs, we unpacked what’s working, what’s broken, and what needs to change.
Here’s what we learned and what we need to start doing differently.